As­traZeneca signs com­pu­ta­tion­al drug dis­cov­ery col­lab­o­ra­tion; J&J-part­nered Fate cleared for the clin­ic

As­traZeneca has picked out its lat­est com­pu­ta­tion­al part­ner from Toron­to, tap­ping Pro­tein­Qure to ap­ply its struc­ture-based de­sign plat­form for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.